BRIEF published on 05/14/2024 at 17:50, 1 year 11 months ago Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
PRESS RELEASE published on 05/14/2024 at 17:45, 1 year 11 months ago Transgene provides business and financial update for Q1 2024 Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024 Clinical Data Q1 2024 Financial Update Transgene TG4050
Published on 05/01/2026 at 07:35, 59 minutes ago Snipp Interactive Reports Financial Results for Q4 and Fiscal 2025; Announces Conference Call on May 5, 2026
Published on 05/01/2026 at 04:00, 4 hours 34 minutes ago Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 5 hours 9 minutes ago McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 5 hours 39 minutes ago GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 7 hours 34 minutes ago PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 08:00, 34 minutes ago CoinShares Digital Securities Limited: CSDS 2025 Audited Financial Statement
Published on 04/30/2026 at 23:39, 8 hours 55 minutes ago Anemoi International Ltd: Final Results For Year Ended 31 December 2025
Published on 04/30/2026 at 20:00, 12 hours 33 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 13 hours 18 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 13 hours 34 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 14 hours 24 minutes ago Minutes of the Combined General Meeting held on April 30, 2026
